At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 315 enrolled
Drug / intervention
AMG 827 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Determine the Safety and Efficacy of AMG 827 in Subjects With Inadequately Controlled Asthma
In Brief
A Phase 2 clinical trial evaluating AMG 827 and Placebo for Asthma. Completed, enrolled 315 participants across 49 sites in 10 countries.
Detailed Summary
The purpose of this study is to determine if AMG 827 is effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesAustria, Belgium, Canada, Finland, Hungary, Netherlands, Poland, Russia, South Korea, United States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2010
Enrollment StartOct 2010
Primary CompletionDec 2011
TodayJul 2026
First PostedSep 10, 2010
Enrollment StartOct 4, 2010
Primary CompletionDec 21, 2011
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.8 years ago
Interventions
AMG 827drug
SC injection.
Placebodrug
SC injection.